1 Intensive Care Department, Hospital Universitari de Bellvitge, Barcelona, Spain.
2 Transplant Procurement Unit, Hospital Universitari de Bellvitge, Barcelona, Spain.
3 Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
4 Cardiac Surgery Department, Hospital Universitari de Bellvitge, Barcelona, Spain.
5 Advance Heart Failure and Cardiac Transplantation Unit, Cardiology Department, Hospital Universitari de Bellvitge, Barcelona, Spain.
6 Cardiothoracic Surgery Department, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
Received 7 June 2020. Revision received 15 October 2020.
Accepted 21 October 2020.
The authors declare no conflicts of interest.
L.A.-C. and G.M.-G. designed, performed a review of the literature, and wrote the article. They also performed the design of the figures. Both authors contributed equally to this article. F.S., J.G.-C., S.T., and E.O.-J. performed a review of the literature and a critical review of the article.
Correspondence: Eva Oliver-Juan, MD, Intensive Care Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga S/N 08907, L’Hospitalet de Llobregat, Barcelona, Spain. ([email protected]).
